| Metric | This Period | Prior Year Same Period | YoY |
|---|---|---|---|
| Revenue | ¥485.8B | ¥488.9B | -0.6% |
| Operating Income | ¥18.9B | ¥19.7B | -4.0% |
| Ordinary Income | ¥19.3B | ¥20.2B | -4.8% |
| Net Income | ¥13.2B | ¥12.4B | +6.0% |
| ROE | 4.8% | 4.7% | - |
For the cumulative results to Q2 of the fiscal year ending March 2026, Revenue was ¥485.8B (¥-3.1B YoY, -0.6%), Operating Income was ¥18.9B (¥-0.8B YoY, -4.0%), Ordinary Income was ¥19.3B (¥-1.0B YoY, -4.8%), and Net Income attributable to owners of the parent was ¥13.2B (¥+0.8B YoY, +6.0%). While there was slight revenue and operating profit decline, Net Income increased due to a reduced tax burden. Gross margin improved to 21.3% (+0.2pt YoY), but a persistently high SG&A ratio of 17.4% pressured the operating margin down to 3.9% (prev. 4.0%). The core Food Manufacturing & Sales segment continues to record a low operating margin of 3.3%, while Real Estate Leasing (margin 70.5%) underpins consolidated profitability. Operating Cash Flow (OCF) improved substantially to ¥16.8B (¥+389.8% vs prior ¥3.4B), securing Free Cash Flow of ¥11.9B. Financial position is solid with a current ratio of 189.7% and an Equity Ratio of 65.0%; Other Comprehensive Income expanded by ¥+4.2B from valuation gains on securities, bringing Comprehensive Income to ¥17.8B. The full-year plan forecasts Operating Income of ¥21.5B (+13.7%) and an Operating Margin of 4.4%, but execution of SG&A efficiency and price/mix improvement are the key monitoring points.
Revenue: Revenue was ¥485.8B (YoY -0.6%), a slight decline. By segment, Food Manufacturing & Sales accounted for ¥481.5B (-0.6%), representing 99.1% of total, while Real Estate Leasing was ¥4.3B (+0.3%). Cost of goods sold was ¥382.3B, yielding a COGS ratio of 78.7% (prev. 78.9%), an improvement of -0.2pt, and Gross Margin rose to 21.3% (prev. 21.1%). Stabilization of raw material and packaging costs contributed, but the margin remains well below industry benchmarks (25–40%). Weak volume growth and price competition underpin the slowdown in topline growth, indicating structural challenges.
Profitability: Gross profit totaled ¥103.5B against SG&A of ¥84.6B (SG&A ratio 17.4%, prev. 17.1%), up +0.3pt, resulting in Operating Income of ¥18.9B (Operating Margin 3.9%). Within SG&A, freight costs of ¥2.0B (4.2% of Revenue) are a major item; structurally high logistics costs impede margin improvement. Non-operating income included ¥0.6B in dividend income within ¥1.2B total non-operating income, and non-operating expenses were ¥0.8B including ¥0.5B in interest expense, resulting in Ordinary Income of ¥19.3B (Ordinary Income Margin 4.0%). Extraordinary gains and losses largely offset (¥0.8B gain on disposal of fixed assets vs ¥0.5B disposal loss), leaving Profit before Income Taxes at ¥19.6B and Income Taxes of ¥6.2B (effective tax rate 31.6%, prev. 32.1%), and Net Income of ¥13.2B. Reduced tax burden turned Net Income positive YoY (+6.0%), although core operations show a decline. Conclusion: slight revenue and operating profit decline (but higher Net Income due to tax effect).
The Food Manufacturing & Sales segment recorded Revenue of ¥481.5B (YoY -0.6%) and Operating Income of ¥15.9B (YoY -4.9%), with an Operating Margin of 3.3% (prev. 3.3%), remaining flat. Although it accounts for 99.1% of Revenue and 84.0% of Operating Income, low margins persist. The Real Estate Leasing segment posted Revenue of ¥4.3B (+0.3%) and Operating Income of ¥3.0B (+1.4%), maintaining a high Operating Margin of 70.5% (prev. 69.6%). It represents 16.0% of Operating Income and contributes to consolidated stability. The margin gap between segments is 67.2pt, highlighting a material challenge to improve the profitability of the core business.
Profitability: Operating Margin 3.9% (prev. 4.0%), Net Margin 2.7% (prev. 2.5%), ROE 4.8% (prev. 5.3%). Despite an improved Gross Margin of 21.3% (+0.2pt YoY), the rise in SG&A ratio to 17.4% (prev. 17.1%) weighed on Operating Margin. ROE declined despite higher Net Income because Shareholders’ Equity increased (+5.6%.)
Cash Quality: OCF/Net Income ratio 1.27x, OCF/EBITDA ratio 0.56x, Accrual ratio -0.8%. Cash backing of earnings is solid, but working capital increases (Inventory +¥4.2B, Accounts Receivable +¥0.9B, Accounts Payable -¥4.3B) have suppressed cash conversion. DSO is 66 days, indicating long collection terms and room for improvement in working capital management.
Investment Efficiency: ROIC 4.9%, near cost of capital and low; CapEx/Depreciation 0.33x, indicating restrained investment below maintenance/replacement levels.
Financial Soundness: Equity Ratio 65.0% (prev. 63.1%), Debt/EBITDA 1.14x, Interest Coverage 55.7x, indicating strong debt tolerance. Current Ratio 189.7%, Quick Ratio 174.3%, Cash/Short-term Debt 1.81x show ample liquidity, but a short-term debt ratio of 73.9% implies continued refinancing dependence that requires monitoring.
OCF improved significantly to ¥16.8B (prior ¥3.4B, +389.8%). OCF subtotal (after Pre-tax Income + non-cash adjustments) was ¥23.0B, including Depreciation of ¥11.2B. Working capital changes were a ¥-4.2B increase in Inventory, ¥-0.9B increase in Accounts Receivable, and ¥-4.3B decrease in Accounts Payable, totaling a ¥-9.4B cash outflow. After corporate tax payments of ¥-6.4B, OCF stood at ¥16.8B. Investing Cash Flow was ¥-4.9B, mainly CapEx of ¥-3.7B and intangible asset investments of ¥-0.9B. Free Cash Flow was ¥11.9B (OCF ¥16.8B + Investing CF ¥-4.9B), stably secured. Financing Cash Flow was ¥-11.9B, including net decrease in short-term borrowings ¥-0.2B, long-term borrowings repayments ¥-4.7B, lease liabilities repayments ¥-3.9B, and dividends paid ¥-3.1B. Cash and deposits were ¥46.1B (prior ¥45.1B), a slight increase. Expansion of working capital (Inventory days 13, DSO 66) impedes cash conversion; inventory optimization and shorter collection terms are priorities.
Most of Ordinary Income of ¥19.3B derives from Operating Income of ¥18.9B; non-operating income of ¥1.2B (dividend income ¥0.6B, other ¥0.4B) is limited to 0.2% of Revenue. Extraordinary gains ¥0.8B (gain on disposal of fixed assets ¥0.8B, gain on sale of investment securities ¥0.1B) and extraordinary losses ¥0.5B (loss on disposal of fixed assets ¥0.5B) are minor, so one-off impacts are limited. The gap between Ordinary Income ¥19.3B and Net Income ¥13.2B (-31.6%) is mainly due to corporate taxes of ¥6.2B (effective tax rate 31.6%), with limited abnormal non-operating items. OCF exceeds Net Income and the accrual ratio is -0.8%, indicating good cash quality, but OCF/EBITDA at 0.56x is low due to working capital expansion. Comprehensive Income of ¥17.8B includes valuation gains on securities of ¥+4.2B and retirement benefit adjustments of ¥+0.2B; the divergence from Net Income (+34.8%) is driven by valuation items. Overall, earnings quality on an ordinary basis is high, with valuation gains inflating comprehensive income.
The full-year plan projects Revenue ¥489.0B (+0.6% YoY), Operating Income ¥21.5B (+13.7%), Ordinary Income ¥21.8B (+13.0%), Net Income attributable to owners of the parent ¥14.6B (+8.8%), and EPS ¥116.03. Progress to-date through Q2 is: Revenue 99.4%, Operating Income 87.9%, Ordinary Income 88.5%, Net Income 90.4% of plan — broadly on track. Operating Margin is expected to improve to 4.4% for the year, up +0.5pt from Q2’s 3.9%, assuming SG&A efficiency and price/mix improvement. Key to achieving the outlook are entrenchment of price revisions in H2 and logistics cost compression (reducing freight costs of ¥2.0B, 4.2% of Revenue). Dividend forecast is ¥15.00 (ordinary dividend only; anniversary special dividend omitted), with a Payout Ratio of 29.1%, at a sustainable level.
The Q2-end dividend was ¥13 (ordinary ¥12 + 88th anniversary commemorative dividend ¥1), and the year-end dividend forecast is ¥13 (same), for an annual dividend of ¥26. Payout Ratio was 22.3% (based on EPS ¥106.70), indicating room. No share buybacks were conducted (Financing CF ¥-0.0B); shareholder returns are dividend-centric. With Free Cash Flow of ¥11.9B versus total dividends of ¥3.1B, FCF coverage is 3.84x, implying high sustainability. The full-year dividend forecast of ¥15.00 reflects the level after omission of the commemorative dividend, and the payout ratio of 29.1% (based on full-year EPS forecast ¥116.03) is stable given financial soundness (Debt/EBITDA 1.14x, Equity Ratio 65.0%). Total Return Ratio is 22.3% (dividends only); no additional buybacks have been indicated, and given ROIC of 4.9% and low capital efficiency, the company likely prioritizes balancing growth investment and dividends.
Risk of entrenched low profitability: Operating Margin of 3.9% is 1.1pt below the industry median of 5.0%, and the core Food Manufacturing & Sales segment margin is low at 3.3%. Gross Margin of 21.3% is far below industry norms (25–40%), revealing weak pricing power and limited resilience to raw material/packaging cost fluctuations. Structural persistence of a high SG&A ratio (17.4%, including logistics 4.2%) reduces operating leverage, making revenue growth less directly effective at improving profits.
Inefficient working capital and cash conversion: OCF/EBITDA 0.56x is low, and working capital expansion (Inventory +¥4.2B, Accounts Payable -¥4.3B) is ongoing. DSO of 66 days and Inventory days 13 indicate room to improve working capital. Continued restrained investment (CapEx/Depreciation 0.33x) risks long-term asset aging and efficiency deterioration. ROIC of 4.9% is close to cost of capital, indicating insufficient returns on invested capital.
Short-term debt concentration and refinancing dependence: Short-term debt ratio is high at 73.9%, with short-term borrowings of ¥25.5B and long-term borrowings maturing within one year of ¥2.7B relying on rollover. Cash/Short-term Debt 1.81x and Interest Coverage 55.7x limit immediate liquidity risk, but rising interest rates could increase refinancing costs. High concentration in the core Food Manufacturing & Sales segment (99.1% of Revenue) amplifies portfolio vulnerability. Valuation fluctuations in Investment Securities of ¥27.4B (6.4% of Total Assets) may increasingly affect Net Assets.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 3.9% | 5.0% (3.3%–8.4%) | -1.1pt |
| Net Margin | 2.7% | 3.2% (1.9%–6.6%) | -0.5pt |
Profitability is below the industry median, placing Operating and Net Margins in the lower range.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth (YoY) | -0.6% | 5.4% (1.0%–8.6%) | -6.0pt |
Revenue growth is well below the industry median, indicating challenges in topline expansion.
※ Source: Company aggregation
Execution of Gross Margin improvement and SG&A efficiency is critical to achieving the full-year plan: Achieving the full-year Operating Margin of 4.4% requires a +0.5pt improvement from Q2’s 3.9%. Although Gross Margin improved to 21.3% (+0.2pt YoY), it remains well below industry levels (25–40%), leaving room for price revisions and expansion of premium/health-focused product mix. Reducing SG&A ratio of 17.4% (including logistics 4.2%) requires logistics efficiency and yield improvements to compress manufacturing costs. The degree of execution on price/mix improvements and SG&A containment in H2 will determine the credibility of the outlook.
Improving working capital management and cash conversion efficiency is a precondition for mid-term profitability improvement: OCF/EBITDA 0.56x is low, and cash outflows from Inventory +¥4.2B and Accounts Payable -¥4.3B restrict OCF quality. Compressing working capital through shortening DSO (66 days) and optimizing inventory days (13 days) is a direct route to improving cash conversion and ROIC (current 4.9%). Continued suppressed CapEx (CapEx/Depreciation 0.33x) risks mid-to-long-term supply capability and efficiency; smoothing growth and efficiency investments is desirable. Financials are robust (Current Ratio 189.7%, Equity Ratio 65.0%), providing investment capacity.
Balancing valuation gains on investment securities with portfolio vulnerability: Investment Securities of ¥27.4B (6.4% of Total Assets, +30.6% YoY) contributed valuation gains of ¥+4.2B, lifting Comprehensive Income to ¥17.8B and supporting Net Assets of ¥276.8B. However, valuation volatility risk is increasing. The high concentration in the core Food Manufacturing & Sales segment (99.1%) contrasts with high-margin Real Estate Leasing (70.5%) which stabilizes earnings; addressing the low margin (3.3%) of the core business and diversifying the portfolio are necessary for mid-to-long-term stable growth.
This report is an earnings analysis document automatically generated by AI analyzing XBRL earnings release data. It does not constitute a recommendation to invest in any particular security. Industry benchmarks are reference information compiled by the company based on public financial statements. Investment decisions are your own responsibility; consult professional advisors as necessary before making investment decisions.